Lifestyle

Beverage: Coffee/Tea/Non-Alcoholic Beverage: Spirits/Beer/Wine Casino/Gaming Fashion Food/Cooking/Baking Health & Fitness Home Goods Hospitality Leisure Activities & Hobbies Parenting Pets Photography Seniors Travel & Tourism
News Release Digital Asset Direct

VOESH New York Unveils Holiday Shop: Featuring Exclusive Holiday Edition Products

VOESH New York

VOESH New York, the leader in clean, vegan body care, is thrilled to announce the launch of its much-anticipated Holiday Shop, bringing a festive touch to self-care routines everywhere. This season, indulge in exclusive holiday edition products featuring the sweet and sensational Golden Vanilla scent that embodies the spirit of the holidays. Whether for personal use or as the perfect gift, VOESH’s holiday offerings promise to make every moment feel special. “The holidays are about sharing joy and love, and what better way to do that than with the gift of clean beauty? Share the glow of radiant, healthy skin this holiday season, and let your loved ones feel the magic of VOESH,” said Vera Oh, Co-Founder of VOESH New York. Introducing Our 2024 Holiday Collection Heel Repair Duo: Get your “mistle-toes” ready for the holiday season! This duo is designed for the ultimate foot care transformation, including VOESH’s Red Moisturizing Heel Socks paired with the Solemate Heel Repair Balm. Perfect for pampering and healing dry, cracked feet, this combination ensures your feet are soft, healthy, and ready for any occasion. The festive red socks add a touch of holiday cheer, making this set a great gift or a treat for yourself. Pedi Moments Golden Vanilla: Experience the perfect at-home pedi for every merry me-time moment with our Pedi Moments kit. This 5-step kit, accompanied by a dual-grit nail file, provides everything you need for a nourishing and soothing pedicure. Infused with the delightful Golden Vanilla scent, this kit transforms your pedicure routine into a spa-like experience. Pedi Moments Duo Golden Vanilla: Elevate your self-care ritual with this deluxe set, featuring two complete Pedi Moments kits. Enjoy the luxurious Golden Vanilla experience twice over, or share the joy by gifting one to a friend. This duo ensures that your feet stay pampered and cared for throughout the holiday season. Golden Vanilla Fragrance Set: Wrap yourself in the comforting aroma of our Golden Vanilla Fragrance Set, which includes a Room & Fabric Fragrance, Hair & Body Fragrance, and Ceramic Fragrance. This set features notes of sweet vanilla bean, golden sugar crystals, and sandalwood, creating a cozy and inviting ambiance perfect for the holidays. Ideal for gifting or adding a touch of holiday spirit to your home. Celebrate the Holidays Early VOESH’s Holiday Shop is opening early, inviting all consumers and retailers to get a head start on holiday shopping. From soothing pedicures to nurturing heel treatments, each product is crafted with clean, high-quality ingredients, ensuring you indulge in self-care that is both luxurious and safe. To explore VOESH’s 2024 Holiday Shop, visit voesh.com. About VOESH New York: Founded in 2013, VOESH New York has emerged as a premier destination for clean and efficacious body care solutions catering to head-to-toe wellness. Noteworthy products include Pedi in a Box, Mani in a Box, the award-winning Shower & Empower Vitamin C Shower Filter, and Collagen Gloves and Socks. VOESH New York is committed to providing 100% vegan, cruelty-free, and sustainable products because every body deserves better beauty! All VOESH New York products are certified by PETA and registered with the US Mocra, EU CPNP and UK SCPN, maintaining vegan, cruelty-free, and dermatologist-tested standards. VOESH New York proudly excludes all 1,680+ EU-banned ingredients and an additional 400+ potentially harmful ingredients. For more information, visit VOESH New York’s website at Voesh.com or contact press@voesh.com. ### All VOESH New York products are certified by PETA and registered with the EU CPNP, and UK SCPN. Always vegan, cruelty-free, and dermatologist-tested, VOESH New York proudly excludes all 1,680+ EU-banned ingredients and an additional 400+ potentially harmful ingredients. VOESH New York products can be found at select Target, Rite Aid, and, Kroger stores nationwide, as well as on voesh.com, amazon.com, walmart.com, and riteaid.com. Contact Details Colleen Mathis +1 917-690-5560 Colleen@absoluterrelations.com Company Website https://voesh.com/

October 15, 2024 08:00 AM Eastern Daylight Time

News Release

Quantum BioPharma Ltd. (NASDAQ: QNTM): Pioneering Alcohol Metabolism Support with Unbuzzd

QNTM

As the health and wellness sector gains momentum, consumers are increasingly seeking products that can aid recovery from the effects of alcohol. Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM), a company focused on developing innovative health solutions, is well-positioned to meet this demand with its groundbreaking product designed to support the body in metabolizing alcohol. Recently, Quantum BioPharma announced a significant business development. On October 7, 2024, its subsidiary, Celly Nutrition Corp, secured a Master Distribution Agreement with FUSION Consulting Group. This agreement could have meaningful implications for the company as it expands the market for its alcohol metabolism product, unbuzzd. The News: Expanding Market Reach Celly Nutrition’s partnership with FUSION, a distributor operating across Puerto Rico, the Caribbean, and parts of Central and South America, could signal a key turning point for Unbuzzd, a product designed to support the body’s natural alcohol metabolization processes. By entering major vacation destinations known for high alcohol consumption, the product will now be distributed through prominent retailers, including Walmart, Walgreens, CVS, Costco, and others. John Duffy, CEO of Celly Nutrition, emphasized the importance of this partnership, stating: “Our partnership with FUSION marks a pivotal moment for Unbuzzd. Their proven success in growing brands across the region will help us expand our footprint while delivering a functional, science-backed product.” Currently available on Amazon in Ready-to-Mix powder sticks, Unbuzzd is also set to launch in Ready-to-Drink 12oz cans. FUSION’s experience distributing other health-conscious beverages like CELSIUS and SHINE Water provides Celly Nutrition with a strategic partner to help Unbuzzd gain traction in these new markets. Why This Matters This development comes at a time when Quantum BioPharma is actively expanding its business model beyond its core focus in biopharmaceuticals. While the company’s primary drug candidate, Lucid-MS, remains in the preclinical stage, Quantum BioPharma’s stake in Celly Nutrition provides a diversification strategy with potential for near-term revenue generation. By retaining a 25.71% ownership stake in Celly Nutrition, Quantum BioPharma is positioned to benefit from any financial success Unbuzzd achieves, with royalties further boosting revenue. Celly Nutrition’s Unbuzzd stands out in the growing wellness and recovery market, offering a solution to help metabolize alcohol faster, promoting clarity, and minimizing aftereffects. With FUSION’s established distribution network, Unbuzzd, now has the opportunity to reach a wider audience, including consumers who may prioritize wellness while still enjoying alcohol responsibly. Eduardo Santacana, CEO of FUSION Consulting Group, expressed enthusiasm about the partnership, stating: “It’s an exciting opportunity to be part of Unbuzzd’s journey. This innovative product helps metabolize alcohol faster, promoting clarity and minimizing the aftereffects of drinking.” With the product entering new markets and retail giants like Walmart and Costco, Unbuzzd’s potential for broad consumer adoption increases, which could contribute meaningfully to Quantum BioPharma’s future financial performance. This partnership underscores Quantum BioPharma’s strategy to diversify and expand its revenue streams. Although the company remains committed to advancing its biopharmaceutical pipeline, particularly with the development of Lucid-MS, its involvement in Celly Nutrition offers a complementary business avenue in the wellness space. As Unbuzz gains traction in markets known for high tourist activity, Quantum BioPharma stands to benefit from the increased visibility and sales that FUSION’s network could generate. The company’s decision to remain invested in Celly Nutrition suggests confidence in the product’s potential to deliver near-term returns. If Unbuzzd continues to resonate with consumers in these key markets, it could help bolster Quantum BioPharma’s financial performance in a way that supports its long-term biopharma ambitions. Conclusion: Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) has taken an important step in expanding its business with Celly Nutrition’s Master Distribution Agreement. This partnership with FUSION Consulting Group has the potential to introduce Unbuzzd to new markets and drive significant sales, complementing Quantum BioPharma’s ongoing drug development efforts. With the potential for sales growth and diversification of its revenue streams, QNTM could emerge as a compelling stock to monitor in the evolving health and wellness market. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performances are not statements of historical fact and may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Awareness Consulting to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only; you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third-party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700 Mark@razorpitch.com Company Website http://razorpitch.com

October 15, 2024 06:00 AM Eastern Daylight Time

Understanding Wagering Requirements: What Every Player Should Know

Acroud Media

An essential guide to help players make the most of their online casino bonuses. Online casino bonuses can be a great way for players to boost their bankroll and extend their gaming sessions, but understanding the wagering requirements tied to these offers is crucial to making the most of them. In this guide, we break down what wagering requirements are, how they affect your bonus, and what players should know before claiming a bonus. What Are Wagering Requirements? Wagering requirements, often called playthrough or rollover requirements, refer to the number of times players must wager the bonus amount (or the combined deposit and bonus) before they can withdraw any winnings. These conditions are attached to most casino bonuses, such as deposit match offers and free spins. For example, if you receive a £100 bonus with a 20x wagering requirement, you’ll need to bet £2,000 (20 x £100) before you can cash out any winnings associated with the bonus. Wagering requirements are commonly found in free spins no deposit bonuses. You can find out more about the best free spins no deposit bonuses and more on how to navigate wagering requirements here. Why Do Casinos Have Wagering Requirements? Casinos use wagering requirements to prevent players from immediately withdrawing bonus funds without using them for gameplay. These conditions ensure that players engage with the casino and games, balancing the rewards casinos offer with the business's operational sustainability. Types of Bonuses with Wagering Requirements Different types of bonuses come with their own wagering conditions. These include: Deposit Match Bonuses: A percentage of your deposit added as bonus funds (e.g., 100% deposit match up to £200). No Deposit Bonuses: Bonuses offered without requiring an initial deposit, often with higher wagering requirements. Free Spins: Winnings from free spins often have wagering requirements before withdrawal is allowed. Cashback Bonuses: Some cashback offers may include wagering on the bonus funds returned to players. How to Calculate Wagering Requirements Wagering requirements can vary, typically ranging from 20x to 50x the bonus amount. Here's how they work in practice: Bonus Only: If the requirement is applied to the bonus only, you multiply the bonus amount by the requirement. Example: A £50 bonus with a 30x wagering requirement means you need to wager £1,500 (30 x £50). Bonus + Deposit: In some cases, the requirement applies to both the bonus and the deposit. Example: A £50 deposit and £50 bonus with a 30x wagering requirement means you must wager £3,000 ([£50 + £50] x 30). Top Tips for Navigating Wagering Requirements For players looking to maximize their bonus experience, here are some key tips to keep in mind: Read the Terms and Conditions: Always check the wagering requirements and other bonus terms before opting in. Look for hidden details like game restrictions or maximum bet limits. Consider the Wagering Multiplier: Lower wagering requirements (20x-30x) are typically more favorable for players and easier to meet. Higher requirements can make it harder to withdraw winnings. Check Game Contributions: Not all games contribute equally to wagering. Slots often contribute 100%, but table games like blackjack or roulette may only contribute 10% or less. Time Limits: Bonuses often come with time limits for meeting wagering requirements, typically between 7 to 30 days. Make sure you’re aware of how long you have to fulfill the conditions. Know Your Maximum Win: Some bonuses cap the amount you can win or withdraw from bonus funds, so check for any maximum payout limits. What to Look for in a Fair Casino Bonus Not all bonuses are created equal. Players should look for: Reasonable Wagering Requirements: Bonuses with 20x to 40x wagering requirements are considered fair and achievable. Transparency in Terms: The best casinos will clearly state all terms and conditions, including wagering requirements, eligible games, and time limits. No Sticky Bonuses: A “sticky” bonus cannot be withdrawn and is deducted from your balance when you cash out. Avoid these when possible, or ensure you understand their terms. It is important to always gamble responsibly, and seek help via one of the following resources if you feel it is necessary. https://www.gamcare.org.uk/ https://www.nhs.uk/live-well/addiction-support/gambling-addiction/ https://www.gambleaware.org/ Contact Details Acroud Media info-media@acroudmedia.com

October 15, 2024 04:24 AM Eastern Daylight Time

Image

William Hill Vegas Partners with Leading Game Developers to Expand Its Casino Offering

Acroud Media

William Hill Vegas, one of the most trusted names in online casino entertainment, is proud to announce a new partnership with the world-renowned game developer Light & Wonder Inc., as part of a strategic effort to expand its casino offering. This collaboration introduces the exciting new slot game "Cash Link Express: Hold & Win", now available to all William Hill Vegas players. With this latest addition, William Hill Vegas continues to strengthen its portfolio, offering a wider variety of games designed to engage and thrill players with innovative features, captivating graphics, and immersive gameplay. A Dynamic New Slot Experience: "Cash Link Express: Hold & Win" The new "Cash Link Express: Hold & Win" slot, developed by Light & Wonder Inc., is set to be a game-changer for William Hill Vegas players. This high-energy, railroad-themed slot takes players on an adventurous journey with exhilarating features, including the popular Hold & Win mechanic, which is already a hit among slot enthusiasts. Designed for both experienced players and newcomers, "Cash Link Express: Hold & Win" offers: Stunning Graphics & Theme: Players are transported to a vibrant, Old West train adventure with high-quality visuals and atmospheric sound design. Hold & Win Feature: The game’s signature mechanic where players can lock in special symbols for a chance to land big wins during the bonus round. Linked Progressive Jackpots: The slot includes four progressive jackpots—Mini, Minor, Major, and Grand—offering the potential for substantial payouts. Exciting Bonus Rounds: Triggering the bonus game opens up more opportunities to win, with free spins and added wild symbols keeping the momentum going. William Hill Vegas' Partnership with Light & Wonder Inc. This new collaboration with Light & Wonder Inc., a leading name in game development and innovation, marks a major milestone for William Hill Vegas. Light & Wonder Inc. is known for producing world-class digital casino content, combining cutting-edge technology with user-centric design. A Growing Collection of Premium Casino Games The introduction of "Cash Link Express: Hold & Win" is part of William Hill Vegas’ broader strategy to continually expand its selection of top-tier casino games, giving players access to the latest innovations in slot gaming. The company is dedicated to partnering with world-class developers like Light & Wonder Inc. to deliver a diverse range of games with something for everyone—from slot enthusiasts to table game aficionados. As part of this strategy, William Hill Vegas regularly introduces new games across various categories, including slots, table games, and live dealer experiences, all while maintaining the highest standards of gameplay, security, and player satisfaction. About Light & Wonder Inc. Light & Wonder Inc. is a global leader in gaming technology and content creation, known for developing engaging, cutting-edge casino games for both land-based and online platforms. With a reputation for innovation, Light & Wonder Inc. continues to push the boundaries of digital gaming by creating visually stunning and mechanically engaging games that capture the imagination of players worldwide. About William Hill Vegas William Hill Vegas is a premier online casino platform offering a wide range of exciting games, from slots and table games to live dealer experiences. Known for its user-friendly interface, secure gaming environment, and commitment to responsible gaming, William Hill Vegas continues to lead the way in online entertainment. With partnerships with leading game developers, William Hill Vegas delivers an unmatched variety of games, ensuring players have access to the most popular and cutting-edge titles in the industry. For a more comprehensive review of William Hill Vegas and to see what other games are available, head over to Metro.co.uk. Contact Details Acroud Media info-media@acroudmedia.com

October 11, 2024 06:58 AM Eastern Daylight Time

Image

The Bermuda Business Development Agency (BDA) Leads Economic Growth as EIRC Initiative Surpasses $500 Million Milestone

Bermuda Business Development Agency

October 10, 2024 – The Bermuda Business Development Agency (BDA) is pleased to announce that the Economic Investment Residential Certificate (EIRC) initiative has surpassed $500 million in investments. This milestone reinforces Bermuda’s position as a premier destination for global investors, showcasing the EIRC’s pivotal role in driving sustained economic growth while enhancing the island’s appeal to high-net-worth individuals seeking both exceptional investments and an unmatched island lifestyle. Since its launch in 2021, The BDA has successfully provided concierge services for all EIRC applicants, guiding them through each phase of the process and ensuring a smooth, seamless experience. This tailored approach has been instrumental in driving economic growth, attracting affluent investors from around the world, including the U.S., U.K., Canada, and Spain. With a minimum investment of $2.5 million, participants gain permanent residency in Bermuda and the flexibility to invest in real estate, new and existing local businesses, Government bonds (previously offered), or social causes. To date, 58 approved applications have driven substantial capital into local enterprises and the property market. The EIRC does however offer more than financial benefits; many certificate holders are drawn to Bermuda because of personal connections, whether through birth, marriage, or long-standing relationships with the island. As a result, these stakeholders are not solely investing capital—they have become part of Bermuda’s community. Data shows that nearly half of a country’s economic growth typically originates from individuals already embedded in the community, and Bermuda is no different. By becoming part of the island’s fabric, these stakeholders unlock even greater opportunities for investment and growth, driving Bermuda’s continued economic success. The Honourable Jason Hayward, Minister of Economy and Labour, commented on the programme's success: "The EIRC initiative has proven to be a vital tool for stimulating economic development in Bermuda. By attracting high-net-worth individuals who are not only investing but also establishing Bermuda as their home, we are creating long-term opportunities for the island. Surpassing the $500 million mark is a significant achievement, and we are confident that the BDA and EIRC programme will continue to contribute positively to Bermuda’s economic growth." Kyle Rogers, Research and Intelligence Manager at the BDA, is also responsible for overseeing the concierge service that supports applicants throughout the entire EIRC process. He ensures seamless management of the certificates, providing crucial guidance from initial inquiry, through comprehensive candidate evaluation, to final approval. He stated, "Reaching $500 million is a testament to Bermuda’s unique offering as both a business hub and an exceptional place to live. The EIRC initiative continues to generate significant value by attracting capital and new residents who are committed to the island’s long-term success. We are excited about the programme’s growth and the bright future ahead." Of the total $500 million investment, $212 million has been directed towards new businesses, $231 million into real estate, $49 million into existing local enterprises, $2.6 million into Government bonds, and $6 million into social ventures deemed beneficial to Bermuda and subject to the Minister’s approval. Jonathan Halata, a developer, investor, and successful EIRC applicant, shared his experience: "As Canadians and Brits, my family has been connected to Bermuda since the 1970s. The EIRC wasn’t just about investing money; it was about building a life for my husband and daughter, and contributing to the community my family has become part of." "My investment in Bermuda extends far beyond financial returns—it's about contributing to the development of premier assets like hotels and tourism infrastructure. Island Realty projects like Azura and Nautilus have brought something unique to Bermuda and created dozens of jobs, which are vital for both airlift and the livelihoods of Bermudians. "I see a direct link between the EIRC programme and Bermuda’s future growth. It’s not just about selling homes—it’s about creating lasting opportunities. Multiplying our experience by 10, 50, or 100 could generate significant new jobs for Bermudians." "The EIRC certificate process was much easier than I expected, especially knowing the complexities with immigration and work permits. The BDA’s white-glove service, with Kyle’s personal attention to detail, made a tremendous difference. They delivered exactly what was promised, with a ribbon on top." For more information on the Economic Investment Residential Certificate and how to apply, visit bda.bm. Media Contact: Simone Gibbons Head of Marketing, Communications & Events D. +1 441 297 7774 | M. +1 441 707 0038 | E: simone@bda.bm The Bermuda Business Development Agency (BDA) encourages direct investment and helps companies start up, re-locate, or expand their operations in our premier jurisdiction. An independent, public-private partnership, we connect you to industry professionals, regulatory officials, and key contacts in the Bermuda government to assist domicile decisions. Contact Details Bermuda’s Business Development Agency (BDA) +1 441-707-0038 info@bda.bm Company Website https://bda.bm

October 10, 2024 02:35 PM Eastern Daylight Time

MedCognetics Introduces the First Embedded AI Cancer Detection System for Mammography Imaging

MedCognetics

MedCognetics, Inc., a company focusing on medical imaging AI, today announced the successful testing and implementation of the first embedded AI image processing and cancer detection system for mammography. The system utilizes the NVIDIA IGX Orin TM medical-grade edge AI platform alongside MedCognetics’ advanced AI-enabled software, CogNet AI-MT, which was developed in collaboration with clinical leaders worldwide. CogNet AI-MT has been trained on a diverse global dataset to enhance the performance of radiologists and help improve patient outcomes worldwide. Incorporating MedCognetics’ new system would allow for AI-driven image enhancement and cancer detection to occur in real-time within the mammography device itself. The embedded solution eliminates latency, delivering immediate, high-quality image analysis, a significant improvement over traditional setups that require external workstations or cloud-based processing. This approach is poised to improve patient outcomes through faster results, enhanced image quality and reduced hardware costs. “Embedding our CogNet AI-MT software directly into mammography imaging equipment means we can enhance image quality and provide immediate cancer detection without the need for costly hardware upgrades,” said Debasish “Ron” Nag, CEO of MedCognetics. “Using the NVIDIA IGX platform, we’re advancing medical imaging technology, making high-quality diagnostic tools more accessible to radiologists and imaging centers around the world.” The NVIDIA IGX Orin platform combines enterprise-level hardware, software, and support. It is purpose-built for industrial and medical edge computing. The platform delivers the performance, durability, security, and safety required for advanced AI applications and features programmable safety extensions, commercial OS support, and powerful AI software. These capabilities, equip organizations to confidently deploy AI safely and securely for enhanced human and machine collaboration. The embedded AI system developed by MedCognetics offers several key benefits: On-Premises Device: Rapid, complete analysis right in the radiology workflow. Enhanced Image Quality: AI-driven enhancements improve the clarity and detail of images without requiring high-end, expensive hardware. Immediate Results: Processing occurs within the device, providing instant analysis and reducing the wait time for results. Cost Efficiency: Medical device manufacturers can achieve high-end image quality at a fraction of the cost by utilizing AI rather than upgrading hardware. Workflow Optimization: Enables worklist prioritization and clinic-determined workflow optimization, enhancing the accuracy and efficiency of radiologists and imaging centers. Easy Upgrades and Maintenance: Software-based solutions are easier to update and maintain, helping to ensure that medical imaging equipment remains cutting-edge without frequent hardware replacements. Earlier this year, MedCognetics was awarded a groundbreaking patent by the United States Patent and Trademark Office (USPTO) for its inclusive, unbiased medical imaging AI technology in mammography. Its expertise in embedded engineering, combined with the NVIDIA IGX platform, is poised to significantly advance medical imaging technology. This work underscores the importance of integrating AI into medical devices to enhance diagnostic capabilities and patient care. For more information about this new embedded AI cancer detection system, visit here. About CogNet AI-MT® CogNet AI-MT is part of MedCognetics' comprehensive CogNet AI™ platform, designed to enhance radiologists' capabilities by expanding insights and awareness in medical imaging. This unbiased platform, trained on a diverse global dataset, advances the performance of radiologists and imaging centers, delivering accurate care for patients worldwide. CogNet AI-MT employs advanced AI and Machine Learning (ML) to detect early signs of cancer across all ethnicities and can be deployed on customer premises, in the cloud, or via the web. The platform is FDA 510(k) cleared for triage of mammogram images. Useful Links: Learn More: www.medcognetics.com Follow us: X | LinkedIn Sales and Partnership Inquiries: Please contact MedCognetics, Inc. at: media@medcognetics.com About MedCognetics, Inc. MedCognetics provides an advanced AI software platform that integrates into radiology workflow. In addition, the AI algorithm is trained on a diverse global patient dataset to mitigate data biasing. The future of AI in healthcare is unbiased services and MedCognetics is at the forefront of creating a more predictable medical outcome and ultimately saving lives. Founded in 2020, the company is based in Dallas, Texas. For more information, please visit our website at www.medcognetics.com. # # # Contact Details ANW Networks Alicia Nieva-Woodgate +1 415-515-0866 alicia@anwnetworks.com Company Website https://www.medcognetics.com

October 10, 2024 11:15 AM Eastern Daylight Time

HUSQVARNA® VIKING® Introduces Epic Quilt™ 97

SVP Worldwide

SVP Worldwide, the parent company of HUSQVARNA® VIKING®, a leader in the sewing industry, proudly announced today the launch of its latest innovation, the Epic Quilt™ 97, what quilt dreams are made of. The Epic Quilt™ 97 boasts a spacious workspace perfect for large projects, accommodating even king-sized quilts. With over 12" (310mm) to the right of the needle and a working area height exceeding 5.5" (140mm), it provides ample room for handling bulky materials. A particular standout feature of the Epic Quilt™ 97 is its sewing projection technology, allowing quilters to preview their stitches before sewing. Stitch preview ensures perfect placement every time. The adjustable lines, angles, and grids in sewing mode make aligning stitches effortless, saving valuable time while achieving precision. The Epic Quilt™ 97 also comes equipped with meticulously designed accessories that enhance creativity and ease of use. Included are advanced accessories providing quilters with the tools needed to elevate their craft to new heights including an Extension Table with Adjustable Guide, Rotating Self Healing Cutting Mat (12” x 12”), Rotary Cutting Tool + Replacement Blades, Ruler Set (6” x 12” and 6” x 6” sizes), Free Motion Ruler Foot, Quilt Binder, HUSQVARNA® VIKING® Universal Needles 80/12 5-Pack and the HUSQVARNA® VIKING® Quilting Needles Assorted Sizes 5-Pack. "We are excited to unveil the Epic 97Q, a groundbreaking advancement in our tradition of innovation,” stated Jason Zielke, chief product officer at SVP Worldwide. “Leveraging AI technology, the machine recommends the optimal sewing foot setup for each stitch, and the built-in projection system simplifies the process of creating complex stitches leading to exceptional precision and quality. We added to this machine a suite of the most important accessories that will advance the quilting experience. The Epic 97Q combines our rich heritage with cutting-edge technology, empowering you to create intricate, beautifully executed quilts with unparalleled ease and accuracy." The Epic Quilt 97 is now available online. For more information, please visit our website at www.husqvarnaviking.com. Media Assets About SVP Worldwide SVP Worldwide is the world’s largest consumer sewing machine company, accounting for approximately one out of every three sewing machines sold globally. The company’s iconic brands - SINGER®, VIKING®, PFAFF®, and mySewnet™, have collectively delighted consumers for over 170 years with a distinct heritage and global fanbase. These premium brands and products are regarded as the first-rate choice for a range of consumers from serious sewists to beginners in crafting. SVP Worldwide operates facilities around the globe that support designing, manufacturing, selling, and supplying the world’s most iconic sewing machine brands. Headquartered out of Nashville, TN (USA) with operations internationally, SVP Worldwide boasts regional headquarters, manufacturing facilities, and commercial offices across Europe, South America, Asia, and Australia. Combined, SVP reaches consumers in more than 180 countries on five continents. SVP brands and products are sold online at www.Singer.com and across a network of sewing machine dealers, mass, online, and specialty retailers, distributors, and through the company’s 130+ internally operated retail stores. In 2021, Platinum Equity acquired the controlling stake in SVP-Singer Holdings, Inc., and its wholly owned subsidiaries ("SVP Worldwide"). To learn more, visit www.svpworldwide.com. Contact Details Razor Sharp PR Ray Young +1 512-694-6097 ray@razorsharppr.com

October 10, 2024 10:00 AM Central Daylight Time

Edit Suits Co. Introduces New Service to Help Men Build Flexible Business Casual Wardrobes

Rev Up Marketers

As more companies shift towards business casual dress codes, Edit Suits Co. is pleased to announce the launch of a new style advisory service. This service aims to assist men in creating versatile wardrobes suitable for both formal and business casual occasions. With the decline of formal dress codes, the traditional suit is no longer a daily necessity. However, this has introduced a new challenge for men: finding coordinated and stylish combinations of jackets, trousers, and shirts. To address this, Edit Suits Co. has developed a service focused on three key principles to ensure every wardrobe remains adaptable and fashionable: Choose Softer Jacket Fits: To achieve a wardrobe that transitions effortlessly from formal to casual, opt for softer fits with soft shoulders and construction. Structured jackets are typically reserved for formal wear, while softer styles work well in both formal and casual settings. Select Textured Fabrics: Fabric selection is crucial when wearing separates. Worsted wool, commonly used for formal suits, may seem out of place when worn as separates. Instead, textured fabrics such as high-twist wool, hopsack, linen, flannel, or brushed cotton are ideal for creating versatile and intentional separates. Opt for Versatile Colours: When building a flexible wardrobe, stick to timeless colours such as blues, greys, browns, and greens. Midnight blue jackets, charcoal trousers, and light beige separates can be easily mixed and matched, ensuring a sharp appearance for any occasion. To experience the new style advisory service and create a personalised, versatile wardrobe, visit one of the Edit Suits Co. showrooms in London, Birmingham, Manchester, or Leeds. About Edit Suits Co.: Edit Suits Co. is a leading provider of custom menswear that specialises in crafting bespoke wardrobes, versatile custom suits, jackets, trousers, and shirts. Their experienced team work closely with each client to create a wardrobe that combines style and confidence in every setting. For more information on how to build a versatile wardrobe visit www.editsuits.com or contact care_uk@editsuits.com. Contact Details Edit Suits Co. Laura Wood +44 20 3795 9003 care_uk@editsuits.com Company Website https://www.editsuits.com

October 10, 2024 04:29 AM Eastern Daylight Time

Image

Silexion Therapeutics to Present at 2024 Maxim Healthcare Virtual Summit

Silexion Therapeutics Corp

Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced its participation in the 2024 Maxim Healthcare Virtual Summit, scheduled to take place from October 15 to 17, 2024. Ilan Hadar, Chief Executive Officer and Dr. Mitchell Shirvan, Chief Scientific and Development Officer will join a fireside chat hosted by Jason McCarthy, Senior Managing Director and Head of Biotechnology Research at Maxim Group, on Thursday, October 17, 2024, at 9:30am ET. The event will be streamed live on M-Vest and accessible to members by clicking here or via following link: https://m-vest.com/events/healthcare-10152024. The Company’s management team will be available for one-on-one meetings throughout the summit. Interested investors are encouraged to contact their Maxim representative to schedule a meeting. About Silexion Therapeutics: Silexion Therapeutics (NASDAQ: SLXN) is a pioneering clinical-stage, oncology-focused biotechnology company developing innovative RNA interference (RNAi) therapies to treat solid tumors driven by KRAS mutations, the most common oncogenic driver in human cancers. The company's first-generation product, LODER™, has shown promising results in a Phase 2 trial for non-resectable pancreatic cancer. Silexion is also advancing its next-generation siRNA candidate, SIL-204, designed to target a broader range of KRAS mutations and showing significant potential in preclinical studies. The company remains committed to pushing the boundaries of therapeutic innovation in oncology, with a focus on improving outcomes for patients with difficult-to-treat cancers. For more information please visit: https://silexion.com Contact Details Silexion Therapeutics Corp Ms. Mirit Horenshtein Hadar, CFO mirit@silexion.com ARX | Capital Markets Advisors North American Equities Desk silexion@arxadvisory.com

October 09, 2024 04:30 PM Eastern Daylight Time

1 ... 5 6 7 8 9 ... 401